Helping projects
change the future
APPLY NOW

Projects

 
 
Acticor Biotech

Acticor Biotech

ACT017 is a unique antithrombotic drug for acute phase of ischemic stroke treatment with a favorable safety profile. The total amount of the round, including the grant financing, investments from Primer Capital, other funds and private investors, is EUR 3.9 million.